Back | Next |
home / stock / apls / apls message board
Subject | By | Source | When |
---|---|---|---|
oh yeah news for the day | IPO$ | investorshub | 04/22/2023 6:45:43 PM |
short data if anyone is interested | IPO$ | investorshub | 04/22/2023 6:13:11 AM |
news all the way baby | IPO$ | investorshub | 04/21/2023 4:04:05 PM |
MomentumIts trading | IPO$ | investorshub | 04/21/2023 9:15:18 AM |
Looks pretty positive | IPO$ | investorshub | 04/20/2023 7:09:59 PM |
MomentumIts gaining last trade up | conix | investorshub | 04/20/2023 1:45:00 PM |
Price trading | IPO$ | investorshub | 04/19/2023 2:29:14 PM |
$APLS what do you make of this data? | IPO$ | investorshub | 04/18/2023 6:29:21 PM |
The trading last up | PickleNick | investorshub | 04/18/2023 8:38:12 AM |
MomentumIts trading | Pedro2004 | investorshub | 04/18/2023 6:51:41 AM |
Price gaining up | conix | investorshub | 04/18/2023 6:49:25 AM |
$APLS Found an interesting article | IPO$ | investorshub | 04/17/2023 10:07:43 PM |
good read | conix | investorshub | 04/17/2023 5:36:08 AM |
$APLS great article | wantprofits | investorshub | 04/16/2023 6:10:11 PM |
$APLS Time for a bounce? | Pedro2004 | investorshub | 04/16/2023 3:53:48 PM |
$APLS bears and bulls | IPO$ | investorshub | 04/15/2023 9:53:54 AM |
bears are running | conix | investorshub | 04/15/2023 1:26:33 AM |
$APLS short squeeze all day | IPO$ | investorshub | 04/14/2023 3:25:09 PM |
bears and bulls | conix | investorshub | 04/13/2023 3:42:02 PM |
Thoughts on where this is headed? | IPO$ | investorshub | 04/13/2023 12:28:59 PM |
News, Short Squeeze, Breakout and More Instantly...
Apellis Pharmaceuticals Inc. Company Name:
APLS Stock Symbol:
NASDAQ Market:
Apellis Pharmaceuticals Inc. Website:
WALTHAM, Mass., June 28, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion on the marketing authorization application (MAA) of i...
2024-06-19 19:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SYFOVRE is the only approved GA treatment to demonstrate a visual function benefit in a prespecified endpoint Data presented at the Clinical Trials at the Summit Meeting WALTHAM, Mass., June 10, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announ...